Cornell AIDS Clinical Trials Unit: A5041 adding GM-CSF to a potent antiretroviral regimen

A5041

What effect does the addition of GM-CSF to a potent antiretroviral regimen have on viral load?

Should you join this clinical trial?
If your viral load is 1500 copies or more and you are on a stable anti-HIV medication regimen, you may be eligible for A5041.

How long will the trial last?
This trial will last for 48 weeks, with clinic visits every 4 - 8 weeks.

More information about the study medications
GM-CSF (Leukine®), an FDA-approved medication for people with leukemia or lymphoma, which is being tested in people with HIV. In the study, you will add GM-CSF or placebo (inactive drug) to your anti-HIV medication regimen.

Call the Cornell Clinical Trials Unit at 212-746-7206 to obtain more information about this study. Always discuss treatment options with your primary care provider before making any changes to your regimen.

HOME